Novel benzylphosphonate compounds of the general formula I: ##STR1## are disclosed as useful in treating bone wasting diseases including postmenopausal osteoporosis in increasing in mammals bone formation and bone mass.
公开了一种通式为I的新型苄基
膦酸酯化合物,用于治疗骨质疏松症等骨质流失疾病,包括增加哺乳动物骨骼形成和骨量的绝经后骨质疏松症。